Skip to main content
Equibles

Legal & General Group Plc

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 764068 London, X0
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$312,292
-$72,223 QoQ
Shares Held
38,988
-18.6% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 209 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. SPRY ranks #154 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in SPRY

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $312,292 38,988
2026-03-31 $384,515 47,885
2025-12-31 $679,986 58,368
2025-09-30 $555,191 55,243
2025-06-30 $956,695 54,825
2025-03-31 $444,588 35,341
2024-12-31 $373,584 35,411
2024-09-30 $491,868 33,922
2024-06-30 $265,570 31,207
2024-03-31 $282,654 27,657
2023-12-31 $154,299 28,157
2023-09-30 $106,432 28,157
2023-06-30 $167,359 24,979
2023-03-31 $420,174 64,543
2022-03-31 $5,763 1,642
2021-12-31 $10,935 1,642
2021-09-30 $37,035 3,711
2021-06-30 $32,218 1,043
2021-03-31 $57,068 1,308
2020-12-31 $602 13